However, olanzapine (5-20 mg) demonstrated a comparable safety profile in female (n=467) as in male patients (n=869).
Ometi ilmnes, et olansapiin (5... 20 mg) omab nii nais - (n=467) kui meespatsientidel (n=869) võrreldavat ohutusprofiili.